About Bio-Techne
Bio-Techne is a company based in Minneapolis (United States) founded in 1981.. The company has 3,100 employees as of June 30, 2025. Bio-Techne has completed 18 acquisitions, including ACD Bio, Asuragen and Atlanta Biologicals. Bio-Techne offers products and services including Reagents and Kits, Analytical Instruments, and ELISA Kits. Bio-Techne operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.
- Headquarter Minneapolis, United States
- Employees 3100 as on 30 Jun, 2025
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bio-Techne Corp
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Bio-Techne
Bio-Techne is a publicly listed company on the NASDAQ with ticker symbol TECH in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Bio-Techne
Bio-Techne offers a comprehensive portfolio of products and services, including Reagents and Kits, Analytical Instruments, and ELISA Kits. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
High-quality reagents for cell culture, assays, and protein analysis in scientific research.
Tools for immunoassays, protein analysis, and diagnostics in life sciences applications.
Kits for detecting and quantifying proteins in research and diagnostic settings.
Unlock access to complete
Software Development Team
92 people
Sales and Marketing
76 people
Leadership Team
40 people
Product Management Team
35 people
Senior Team
31 people
Finance and Accounting
20 people
Human Resources and Administration
18 people
Advanced Team
13 people
Unlock access to complete
Funding Insights of Bio-Techne
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $152,999
-
First Round
First Round
(01 May 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Grant - Bio-Techne | Valuation |
investors |
|
| Mar, 2016 | Amount | Grant - Bio-Techne | Valuation |
investors |
|
| Aug, 2014 | Amount | Grant - Bio-Techne | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bio-Techne
Bio-Techne has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bio-Techne
Bio-Techne has strategically engaged in corporate development activities, having acquired 18 companies. Notable acquisitions include ACD Bio, Asuragen and Atlanta Biologicals. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of solutions for gene editing and gene delivery
|
2015 | ||||
|
Microfluidic-based instruments for tumor analysis are developed.
|
2014 | ||||
|
Single-cell sorting instruments are developed using microfluidic technology.
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Bio-Techne
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bio-Techne Comparisons
Competitors of Bio-Techne
Bio-Techne operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Portfolio of products and services for life science research and clinical diagnostic markets
|
|
| domain | founded_year | HQ Location |
AI-based medical diagnostics are developed for healthcare applications.
|
|
| domain | founded_year | HQ Location |
Merck is engaged in science and technology solutions globally.
|
|
| domain | founded_year | HQ Location |
Assay kits for ultra-sensitive biomarker detection are developed.
|
|
| domain | founded_year | HQ Location |
Primary antibodies and instruments for immunohistochemistry are manufactured.
|
|
| domain | founded_year | HQ Location |
Tissue hypothermic storage and cryopreservation freeze media are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bio-Techne
Frequently Asked Questions about Bio-Techne
When was Bio-Techne founded?
Bio-Techne was founded in 1981 and raised its 1st funding round 28 years after it was founded.
Where is Bio-Techne located?
Bio-Techne is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
How many employees does Bio-Techne have?
As of Jun 30, 2025, the latest employee count at Bio-Techne is 3,100.
What is the annual revenue of Bio-Techne?
Annual revenue of Bio-Techne is $1.22B as on Jun 30, 2025.
What does Bio-Techne do?
Bio-Techne was founded in 1981 in Minneapolis, United States, within the biotechnology sector. Specialized proteins such as cytokines and growth factors are supplied, alongside antibodies, immunoassays, biologically active small molecules, and other reagents to research, diagnostics, and clinical control markets. Instrumentation is provided to streamline protein analysis processes for customers in these areas. Operations focus on supporting scientific and medical applications across the United States and internationally.
Who are the top competitors of Bio-Techne?
Bio-Techne's top competitors include Biocare Medical, Merck and Siemens Healthineers.
What products or services does Bio-Techne offer?
Bio-Techne offers Reagents and Kits, Analytical Instruments, and ELISA Kits.
Is Bio-Techne publicly traded?
Yes, Bio-Techne is publicly traded on NASDAQ under the ticker symbol TECH.
How many acquisitions has Bio-Techne made?
Bio-Techne has made 18 acquisitions, including ACD Bio, Asuragen, and Atlanta Biologicals.
Who are Bio-Techne's investors?
Bio-Techne has 1 investor. Key investors include HHS.
What is Bio-Techne's ticker symbol?
The ticker symbol of Bio-Techne is TECH on NASDAQ.